The effects of early intravenous pamidronate treatment on infants with moderate to severe Osteogenesis Imperfecta

被引:0
|
作者
Alcausin, M. B. [1 ]
Ault, J. [1 ]
Pacey, V. [1 ]
Briody, J. [1 ]
McQuade, M. [1 ]
Sillence, D. O. [1 ,2 ]
Munns, C. F. J. [1 ,2 ]
机构
[1] Childrens Hosp Westmead, Westmead, NSW, Australia
[2] Univ Sydney, Dept Paediat & Child Hlth, Sydney, NSW 2006, Australia
关键词
D O I
10.1016/j.bone.2009.01.428
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
231
引用
收藏
页码:S68 / S68
页数:1
相关论文
共 50 条
  • [1] Intravenous pamidronate treatment of infants with severe osteogenesis imperfecta
    Astrom, Eva
    Jorulf, Hakan
    Soderhall, Stefan
    ARCHIVES OF DISEASE IN CHILDHOOD, 2007, 92 (04) : 332 - 338
  • [2] Effects of intravenous pamidronate treatment in infants with osteogenesis imperfecta: Clinical and histomorphometric outcome
    Munns, CFJ
    Rauch, F
    Travers, R
    Glorieux, FH
    JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (07) : 1235 - 1243
  • [3] Intravenous pamidronate treatment in osteogenesis imperfecta
    Bembi, B
    Parma, A
    Bottega, M
    Ceschel, S
    Zanatta, M
    Martini, C
    Ciana, G
    JOURNAL OF PEDIATRICS, 1997, 131 (04): : 622 - 625
  • [4] Intravenous pamidronate treatment in osteogenesis imperfecta
    Fujiwara, I
    Ogawa, E
    Igarashi, Y
    Ohba, M
    Asanuma, A
    EUROPEAN JOURNAL OF PEDIATRICS, 1998, 157 (03) : 261 - 262
  • [5] Respiratory distress with pamidronate treatment in infants with severe osteogenesis imperfecta
    Munns, CF
    Rauch, F
    Mier, RJ
    Glorieux, FH
    BONE, 2004, 35 (01) : 231 - 234
  • [6] Pamidronate treatment of children with moderate to severe osteogenesis imperfecta: a note of caution
    Alharbi, Mohammed
    Pinto, Graziella
    Finidori, Georges
    Souberbielle, Jean claude
    Guillou, Florence
    Gaubicher, Solenn
    Le Merrer, Martine
    Polak, Michel
    HORMONE RESEARCH, 2006, 65 : 126 - 126
  • [7] Osteogenesis imperfecta and intravenous pamidronate
    Banerjee, I
    Shortland, GJ
    Evans, WD
    Gregory, JW
    ARCHIVES OF DISEASE IN CHILDHOOD, 2002, 87 (06) : 562 - 563
  • [8] Pamidronate Treatment of Children with Moderate-to-Severe Osteogenesis Imperfecta: A Note of Caution
    Alharbi, M.
    Pinto, G.
    Finidori, G.
    Souberbielle, J. C.
    Guillou, F.
    Gaubicher, S.
    Le Merrer, M.
    Polak, M.
    HORMONE RESEARCH, 2009, 71 (01) : 38 - 44
  • [9] Intravenous pamidronate treatment on children with moderate to severe osteogenesis imperfecta started less than 36 months of age
    Alcausin, M. B.
    Ault, J.
    Pacey, V.
    Briody, J.
    McQuade, M.
    Sillence, D. O.
    Munns, C. F. J.
    BONE, 2009, 45 : S90 - S91
  • [10] Intravenous Pamidronate Treatment in Children with Moderate-to-Severe Osteogenesis Imperfecta Started under Three Years of Age
    Alcausin, M. B.
    Briody, J.
    Pacey, V.
    Ault, J.
    McQuade, M.
    Bridge, C.
    Engelbert, R. H. H.
    Sillence, D. O.
    Munns, C. F.
    HORMONE RESEARCH IN PAEDIATRICS, 2013, 79 (06): : 333 - 340